2
Clinical Trials associated with AleetoSingle-arm, open-label, single-center clinical trial of the safety and preliminary efficacy of ALEETO in the treatment of mild to moderate Alzheimer's disease
Start Date26 Mar 2024 |
Sponsor / Collaborator- |
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With Amyotrophic Lateral Sclerosis
This study is a single-center, randomized, double-blind, placebo parallel-controlled, dose-escalation clinical study. The aim of this study was to evaluate the safety, tolerability, and preliminary effect of Aleeto in adult patients with ALS, and to provide an appropriate dose for the future clinical trial.
100 Clinical Results associated with Aleeto
100 Translational Medicine associated with Aleeto
100 Patents (Medical) associated with Aleeto
100 Deals associated with Aleeto